Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation

Journal of Nuclear Medicine

Volumn 54, Issue 5, 2013, Pages 748-755

  Bettenworth, Dominik ^a   Reuter, Stefan ^a   Hermann, Sven ^a   Weckesser, Matthias ^a   Kerstiens, Linda ^a   Stratis, Athanasios ^a   Nowacki, Tobias Max ^a   Ross, Matthias ^a   Lenze, Frank ^a   Edemir, Bayram ^a   Maaser, Christian ^b   Pap, Thomas ^a   Koschmieder, Steffen ^a   Heidemann, Jan ^a   Schaf̈ers, Michael ^a   Lug̈ering, Andreas ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b University Teaching Hospital Luneburg   (Germany)

Author keywords

18F FDG PET CT; Inflammatory bowel disease; Murine colitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE; DEXTRAN SULFATE; DIAGNOSTIC AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL INFILTRATION; CELL SELECTION; CELL TYPE; COLITIS; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE COURSE; DRUG UPTAKE; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MOUSE; NEUTROPHIL; NON INVASIVE PROCEDURE; NONHUMAN; PET SCANNER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; 18F-FDG PET/CT; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; GRANULOCYTE; IMMUNOLOGY; MURINE COLITIS; SCINTISCANNING;

18F-FDG PET/CT; INFLAMMATORY BOWEL DISEASE; MURINE COLITIS;

ANIMALS; COLITIS; DEXTRAN SULFATE; ENDOSCOPY, GASTROINTESTINAL; FLUORODEOXYGLUCOSE F18; GRANULOCYTES; HUMANS; MICE; MICE, INBRED C57BL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84877117490     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.112623     Document Type: Article

References (28)

1. Vucelic B. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Dig Dis. 2009;27:269-277.
2. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1657. (Pubitemid 46722637)
3. Rodríguez-Reyna TS, Martinez-Reyes C, Yamamoto-Furusho JK. Rheumatic manifestations of inflammatory bowel disease. World J Gastroenterol. 2009;15:5517-5524.
4. Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease: results from a prospective population-based study. Gut. 2008;57:1518-1523.
5. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13-20. (Pubitemid 32061864)
6. Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology. 138:463-468; quiz e410-461.
7. Byrne FR, Viney JL. Mouse models of inflammatory bowel disease. Curr Opin Drug Discov Devel. 2006;9:207-217.
8. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621.
9. Hindryckx P, Staelens S, Devisscher L, et al. Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using muPET/CT. Inflamm Bowel Dis. 2011;17:2058-2064.
10. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35-45.
11. Spier BJ, Perlman SB, Jaskowiak CJ, Reichelderfer M. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol. 2010;12:85-88.
12. Spier BJ, Perlman SB, Reichelderfer M. FDG-PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging. 2009;53:64-71.
13. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694-702. (Pubitemid 20069706)
14. Dieleman LA, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114:385-391. (Pubitemid 28539597)
15. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 2000;62:240-248.
16. 18F-FDG. J Nucl Med. 2005;46:1522-1530.
17. Reuter S, Schnockel U, Schroter R, et al. Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET. PLoS ONE. 2009;4:e5296.
18. Bettenworth D, Buyse M, Bohm M, et al. The Tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function. Am J Pathol. 2011;179:1230-1242.
19. Schäfers KP, Reader AJ, Kriens M, Knoess C, Schober O, Schafers M. Performance evaluation of the 32-module quadHIDAC small-animal PET scanner. J Nucl Med. 2005;46:996-1004. (Pubitemid 43733515)
20. Zwerina J, Redlich K, Polzer K, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA. 2007;104:11742-11747. (Pubitemid 47175083)
21. Koschmieder S, Gottgens B, Zhang P, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood. 2005;105:324-334. (Pubitemid 40053100)
22. Toriihara A, Yoshida K, Umehara I, Shibuya H. Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging. Ann Nucl Med. 2011;25:173-178.
23. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30:983-989.
24. Gonçalves A, Viret F, Ciccolini J, et al. Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors. Clin Cancer Res. 2003;9:102-108. (Pubitemid 36109721)
25. 18F]fluoro-D-glucose and positron emission tomography. Gastroenterology. 2008;135:744-755.
26. Meisner RS, Spier BJ, Einarsson S, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:993-1000. (Pubitemid 47309971)
27. Louis E, Ancion G, Colard A, Spote V, Belaiche J, Hustinx R. Noninvasive assessment of Crohn's disease intestinal lesions with 18F-FDG PET/CT. J Nucl Med. 2007;48:1053-1059. (Pubitemid 47052642)
28. Chandler MB, Zeddun SM, Borum ML. The role of positron emission tomography in the evaluation of inflammatory bowel disease. Ann N Y Acad Sci. 2011;1228:59-63.